Original Article

Preventing Ventilator‐Associated Pneumonia in the United States: A Multicenter Mixed‐Methods Study

Sarah L. Krein, PhD, RN; Christine P. Kowalski, MPH; Laura Damschroder, MS, MPH; Jane Forman, ScD, MHS; Samuel R. Kaufman, MA; Sanjay Saint, MD, MPH  

From the Department of Veterans Affairs Ann Arbor Health Services Research and Development Center of Excellence, Department of Veterans Affairs Ann Arbor Healthcare System (S.L.K., C.P.K., L.D., J.F., S.S.), the Department of Internal Medicine, University of Michigan Medical School (S.L.K., S.R.K., S.S.), and the Ann Arbor Department of Veterans Affairs–University of Michigan Patient Safety Enhancement Program (S.R.K., S.S.), Ann Arbor, Michigan.

Address reprint requests to Sarah L. Krein, PhD, RN, Veterans Affairs Ann Arbor Health Services Research and Development Center of Excellence, Veterans Affairs Ann Arbor Healthcare System, PO Box 130170, Ann Arbor, MI 48113 (skrein@umich.edu).

Objective. To determine what practices are used by hospitals to prevent ventilator‐associated pneumonia (VAP) and, through qualitative methods, to understand more fully why hospitals use certain practices and not others.

Design. Mixed‐methods, sequential explanatory study.

Methods. We mailed a survey to the lead infection control professionals at 719 US hospitals (119 Department of Veterans Affairs [VA] hospitals and 600 non‐VA hospitals), to determine what practices are used to prevent VAP. We then selected 14 hospitals for an in‐depth qualitative investigation, to ascertain why certain infection control practices are used and others not, interviewing 86 staff members and visiting 6 hospitals.

Results. The survey response rate was 72%; 83% of hospitals reported using semirecumbent positioning, and only 21% reported using subglottic secretion drainage. Multivariable analyses indicated collaborative initiatives were associated with the use of semirecumbent positioning but provided little guidance regarding the use of subglottic secretion drainage. Qualitative analysis, however, revealed 3 themes: (1) collaboratives strongly influence the use of semirecumbent positioning but have little effect on the use of subglottic secretion drainage; (2) nurses play a major role in the use of semirecumbent positioning, but they are only minimally involved with the use of subglottic secretion drainage; and (3) there is considerable debate about the evidence supporting subglottic secretion drainage, despite a meta‐analysis of 5 randomized trials of subglottic secretion drainage that generally supported this preventive practice, compared with only 2 published randomized trials of semirecumbent positioning, one of which concluded that it was ineffective at preventing the development of VAP.

Conclusion. Semirecumbent positioning is commonly used to prevent VAP, whereas subglottic secretion drainage is used far less often. We need to understand better how evidence related to prevention practices is identified, interpreted, and used to ensure that research findings are reliably translated into clinical practice.

Received April 14, 2008; accepted June 22, 2008; electronically published August 20, 2008.

Ventilator‐associated pneumonia (VAP) is the most common type of hospital‐acquired infection seen in the intensive care unit (ICU).1 VAP occurs in 10%–20% of patients receiving mechanical ventilation for more than 48 hours and is associated with substantial morbidity, mortality, and excess healthcare costs.2 Various strategies to prevent VAP have been evaluated, most focusing on preventing oropharyngeal or gastric colonization by pathogens and the aspiration of contaminated secretions. Published guidelines36 describe several specific preventive practices, including the use of semirecumbent positioning of ventilated patients, aspiration of subglottic secretions by using specialized endotracheal tubes, selective digestive tract decontamination, use of antimicrobial mouth rinse, and use of specialized kinetic beds. Recently, interest has focused on practice “bundles,” sets of practices implemented together.79

Unfortunately, few data exist regarding the strategies that US hospitals use to prevent VAP. Moreover, little is known about what factors influence the use of these strategies. The purpose of this mixed‐methods, sequential explanatory study was to determine, by use of a quantitative survey, what practices US hospitals use for the prevention of VAP and to understand, by use of qualitative analysis, why hospitals are using some practices but not others.

Methods

 

Study Design

This study is part of a larger project focusing on the prevention of hospital‐acquired infections in US hospitals.1012 We combined quantitative and qualitative data to allow for a more detailed analysis of the complex phenomena that are inherent in the delivery of healthcare services.13,14 First, in May 2005, we sent a survey to the lead infection control professionals (ICPs) at 719 US hospitals. The survey sample consisted of all Department of Veterans Affairs (VA) medical centers (n = 119), which are part of the country’s largest centralized healthcare delivery system, and a national, stratified, random sample of non‐VA general medical and surgical hospitals with 50 or more beds and an ICU (n = 600). Data were also obtained from the 2005 American Hospital Association (AHA) database and the 2003 Area Resource File.15

The survey responses were then used to implement a stratified purposeful sampling strategy,13 resulting in the selection of 14 hospitals for an in‐depth qualitative investigation. We first stratified by hospital size, then looked at our quantitative results to determine the typical infection control practices used by hospitals in each stratum, and selected hospitals with typical uses as well as hospitals with atypical uses of specific practices. The selection of hospitals also focused on achieving the maximum variation in the other relevant variables, such as whether the hospital was a VA or non‐VA facility. Semistructured telephone interviews were conducted with key stakeholders at all 14 hospitals, and 6 of the 14 hospitals were subsequently selected for a visit.

Institutional review board approval was obtained from the VA Ann Arbor Healthcare System as well as from each of the hospitals that were visited.

Survey Measures

At each acute care facility, respondents were asked how frequently certain infection control practices were used for adults who received mechanical ventilation. Frequency of practice was measured on a scale from 1 to 5 (in which 1 indicated “never” and 5 indicated “always”), with “regular use” defined as a rating of 4 or 5. Practices of interest included the use of semirecumbent positioning, the use of antimicrobial mouth rinse, aspiration of subglottic secretions by using specialized endotracheal tubes, and the use of specialized kinetic beds that oscillate. These practices were selected because there is supporting evidence for each in the literature, and they are all discussed in the Centers for Disease Control and Prevention (CDC) guidelines for preventing healthcare‐associated pneumonia.3

We also asked respondents whether the facility had a hospital epidemiologist, whether the lead ICP was certified in infection control and epidemiology, and whether the facility was participating in a collaborative effort to encourage use of infection control practices. Academic affiliation was defined as having residency training approval by the Accreditation Council for Graduate Medical Education as specified in the AHA database. The AHA database was also used to derive a measure of nurse staffing (full‐time equivalent nurses per adjusted average daily census), which has been shown to be related to patient outcomes and safety.1618

Qualitative Data Collection

A total of 38 semistructured telephone interviews were conducted at 14 hosptals. The interviews were audio recorded and transcribed. Multiple interviews were conducted at each hospital (2–4 interviews ranging from 29 to 92 minutes) to get the perspectives of staff in different positions. The telephone interviews were conducted during the period from July 2005 to May 2006. The first point of contact was the lead ICP. Thereafter, we used a snowball technique whereby interviewees were asked to recommend other potential interviewees, particularly individuals who were involved in decisions related to the use of at least 1 of the infection control practices of interest. Interviewees were asked to identify which practices their organization used to prevent VAP and to discuss the decision‐making process that led their organization to use those practices (see Appendix). Interviewees were also asked about practices that were not used and why.

During the period from October 2006 to October 2007, there were 48 additional interviews conducted during visits to 6 hospitals. The hospital visits provided an opportunity to gather more in‐depth information and to confirm or explore issues mentioned during the telephone interviews. Interviewees from a wide variety of staff positions were purposefully selected because they provided different perspectives (eg, senior executives) or because they were directly involved in infection control (eg, hospital epidemiologists).

Statistical Analysis

Given our stratified sampling approach, survey data were analyzed by using sample weights based on the probability of selection in each stratum, which resulted in estimates that represented the full population of VA hospitals and non‐VA acute care hospitals with 50 or more hospital beds and an ICU. Results were reported either as weighted proportions or as weighted mean values, with 95% confidence intervals (CIs). We used weighted logistic regression to determine which hospital characteristics (as described above) were associated with the use of each infection prevention practice, while simultaneously adjusting for other factors such as the facility’s number of ICU beds. Logistic regression results were presented as odds ratios (ORs) with 95% CIs. All reported P values are 2 tailed, and all analyses were conducted using Stata, version 9.0 (StataCorp).

The qualitative analysis was conducted using rigorous qualitative procedures.13,19 First, we established a preliminary codebook that was based on our study’s conceptual model. This codebook was revised by having 4 members of the research team independently code 2 transcripts and then meet to discuss the codes. Because of the complex and dense nature of our data and our use of interpretive codes, we chose a consensus approach to coding the data.20,21 Two team members coded each transcript independently and then discussed the coded transcript and resolved any discrepancies. The interviews and codes were entered into a qualitative computer analysis program (NVivo7; QSR International). Our qualitative analysis was guided by quantitative findings and sought to explain and confirm those findings. We also identified factors, in addition to those included in our quantitative analysis, that influenced the use of VAP prevention practices, and we explicitly sought out and highlighted examples that were contrary to expected findings, to ensure the rigor of our analysis.

Results

 

Quantitative Survey

The survey response rate was 72%. Table 1 shows the characteristics of the responding hospitals. In our sample, 83% of the hospitals reported regularly using semirecumbent positioning, 40% regularly used antimicrobial mouth rinse, 21% regularly used subglottic secretion drainage, and 18% regularly used kinetic beds.

Table 1. 
Table 1.  Characteristics of Hospitals Responding to a Survey Determining Practices Used to Prevent Ventilator‐Associated Pneumonia

Open New Window

Multivariable logistic regression analysis (Table 2) revealed that hospitals participating in a collaborative were more than twice as likely to use semirecumbent positioning (OR, 2.6 [95% CI, 1.44–4.80]). Higher nurse‐staffing levels also appeared to be associated with the use of semirecumbent positioning (OR, 1.8 [95% CI, 0.91–3.58]), although this association was not statistically significant ( ). Finally, if the ICP was certified in infection control, the facility was significantly more likely to report regular use of subglottic secretion drainage (OR, 2.4 [95% CI, 1.21–4.65]). None of our measured characteristics were associated with use of kinetic beds or antimicrobial mouth rinse.

Table 2. 
Table 2.  Results of Multivariable Logistic Regression Analysis to Determine Regular Use of Practices to Prevent Ventilator‐Associated Pneumonia

Open New Window

Qualitative Themes

The characteristics of the 14 hospitals where telephone interviews took place and of the 6 hospitals where in‐person interviews took place that were included in the qualitative phase of the study are shown in Table 3, and the characteristics of all interviewees are shown in Table 4. Of particular interest with regard to our quantitative data was the contrast between the use of semirecumbent positioning and the use of subglottic secretion drainage, because, according to the CDC guidelines for preventing healthcare‐associated pneumonia, implementation of both practices is suggested and both are supported by suggestive clinical or epidemiologic studies or by strong theoretical rationale (ie, category II recommendations).3 Thus, we used qualitative data to identify underlying mechanisms that would help explain these results. The following 3 themes emerged from the qualitative analysis: (1) the use of collaboratives and practice “bundles”; (2) nurse‐staffing levels and the role played by nurses in the use of infection controal practices; and (3) the perceived level of evidence supporting a practice.

Table 3. 
Table 3.  Characteristics of the Hospitals Where Interviews Took Place to Understand Regular Use of Practices to Prevent Ventilator‐Associated Pneumonia

Open New Window

Table 4. 
Table 4.  Characteristics of the 86 Hospital Staff Members Interviewed to Understand Regular Use of Practices to Prevent Ventilator‐Associated Pneumonia

Open New Window

Collaboratives. Qualitative analysis confirmed the association between the participation in a collaborative and the use of semirecumbent positioning, but it revealed no association between collaborative participation and the use of subglottic secretion drainage. In particular, participation in a collaborative was identified as positively influencing the use of semirecumbent positioning, by focusing attention on the practice and by encouraging systematic monitoring, feedback, and reinforcement. A physician administrator at one hospital stated that “for many years people have tried to…advocate for semirecumbent positioning but it’s always been sort of a flavor of the month…the [collaborative] initiative began to focus on how to hardwire some of these not totally exotic practices…” A nurse at another facility noted that “…it wasn’t until the [collaborative] that all the intensivists were fully behind the whole project…once the graphs started going up, once people started seeing results, it was just part of their normal daily practice.”

Nurse staffing. Although staffing levels were not explicitly discussed during our interviews, our qualitative analysis revealed, as suggested by our quantitative data, that nurses play an important role in the use of semirecumbent positioning. Likewise, there was essentially no mention in our interviews of the active involvement of nurses in the use of subglottic secretion drainage. When describing the use of semirecumbent positioning, the interviewees identified nurses as key facilitators at several hospitals, although a few also mentioned nurses as barriers to the practice (often due to nurses' resistance or misperceptions).

While describing the role of nurses in successfully implementing the use of semirecumbent positioning, a chief of staff noted that “…the nurses are really outstanding and they…actually make it [semirecumbent positioning] happen…it doesn’t depend on the vagaries of which attending is on call.” Similarly, when asked who promoted the use of semirecumbent positioning, a nurse at one facility stated that “…it was just the nursing staff, the charge nurses, it was me [a nurse] going around talking about it.”

Although nurses were identified as key facilitators, they were also described by some as potential barriers to the regular use of semirecumbent positioning. The nurse manager of a medical ICU explained how she encountered resistance from some nurses: “…many of my nurses have been here many years…so when you have evidence‐based practice and you have to make changes, it’s just hard switching.” In addition, nurses’ misperceptions were another common issue. As described by an ICU nurse, “…probably the biggest challenge was that the nurses thought that they were already putting the head of the bed up 30° but if you looked at the angle of the bed it was only 20.”

Nurses also facilitated the use of this practice (ie, semirecumbent positioning) by regular monitoring. One nurse described how she and other staff nurses would ask why the head of the bed was not up, thereby becoming, as she phrased it, “the head of the bed police.…” However, other professional staff were also involved in monitoring this practice at some hospitals. For example, a respiratory therapist described how a pharmacist became involved with monitoring: “he was checking off all of these items…he started out with just the sedation and the weaning protocol and, he thought well, I may as well add that [monitoring head of bed elevation].…”

Perceived level of evidence. None of our respondents described any debate about the evidence supporting semirecumbent positioning to prevent VAP. As the director of a medical ICU observed, “something like head of bed, you’d say, there’s no downside.” This general acceptance, with little discussion of the evidence, is in strong contrast to how decisions to use or not use subglottic secretion drainage were made at several hospitals. An ICP at one hospital that was not using subglottic secretion drainage explained that “there certainly is interest by our intensivists…they think it shows promise…[but] they’re not convinced there’s definitive evidence that it prevents VAP.” At another hospital, a critical care physician explained the lack of use of subglottic secretion drainage this way: “Well because I think if you look at the literature, it’s a little bit questionable and it really looks like oral decontamination by frequent mouth washing is probably sufficient.”

At hospitals using subglottic secretion drainage, it was often used only for certain patients or on a trial basis, and, even at these hospitals, the perception of the evidence was mixed. The hospital epidemiologist at one hospital that had used subglottic secretion on a trial basis stated “I think that the recommendations in the CDC guideline…might be a tad more enthusiastic than the number of studies and the data actually support.” When asked about why they were using subglottic secretion drainage, a physician explained “I think a series of articles over the years that suggested they significantly reduced VAP. It was the biologic plausibility that made sense.”

Other reasons for not using, or for selectively using, subglottic secretion drainage were cost and mechanical issues, such as tube rigidity. However, as one physician noted, “if you look at them, they’re not that expensive…so I don’t think honestly that that’s a very strong argument, although it is the argument that everyone raises.” Furthermore, in several cases, the concerns expressed were based on hearsay and not personal experience. For example, as described by a physician, “I’d heard from everybody I’d asked that these [subglottic secretion drainage endotracheal tubes] were hard to keep patent, to make actually work, that they took a lot of tinkering…they kept clogging and it was like a nightmare.”

Discussion

 

Several findings emerged from this multicenter, mixed‐methods study. Specifically, the practice of semirecumbent positioning to prevent VAP is used by a large percentage of US hospitals, whereas other practices—including the use of antimicrobial mouth rinse, kinetic beds, and subglottic secretion drainage—are used by far fewer hospitals. Particularly notable is the contrast between the use of semirecumbent positioning (used by more than 80% of hospitals) and the use of subglottic secretion drainage (used by approximately 20% of hospitals), given that recommendations in the CDC guidelines indicate the same level of support for both practices.3

Quantitative and qualitative findings suggest that hospitals participating in a collaborative greatly increased their routine use of semirecumbent positioning but that this participation had little effect on their use of subglottic secretion drainage. Similarly, both sources of data (quantitative and qualitatiave) support the key role played by nurses in instituting semirecumbent positioning of patients receiving mechanical ventilation and their minimal involvement in the use of subglottic secretion drainage. Although our quantitative results provided few insights into the lack of use of subglottic secretion drainage, our qualitative data were quite illuminating. Disagreement about the strength of the evidence supporting the use of subglottic secretion drainage was a key factor limiting its use, compared with semirecumbent positioning, which generated no apparent dispute.

The study results highlight the important role that collaboratives play in addressing hospital‐acquired infection but also suggest that this effect may be specific to certain practices. Collaboratives—which bring together teams from different organizations to work together in a structured fashion—are increasingly popular for facilitating the spread of evidence‐based practices and improving quality of care.2224 In the United States, collaborative initiatives, such as the Institute for Healthcare Improvement 100,000 Lives Campaign, have focused on preventing VAP by use of a practice bundle, which includes the use of semirecumbent positioning.7,8 As noted in Krein et al.,11 collaborative membership is associated with the use of several practices to prevent central venous catheter–related bloodstream infection. However, this association is most evident when the practice is included in a practice bundle, which seems to be taken as evidence for its effectiveness.25 So, although practice bundles may be a powerful tool for change, this approach warrants careful investigation, to prevent rapid, but misguided, increases in the use of potentially ineffective practices. Another possible risk is that a focus on certain practices can divert attention from other novel technologies. In this analysis, however, we did not find explicit evidence to suggest that participation in a collaborative was related to decreased use of a newer practice that is not part of a bundle, such as subglottic secretion drainage.

Studies have identified an association between higher nurse‐staffing levels and better patient outcomes, including decreases in hospital‐acquired infections.1618 In our study, the level of nurse staffing was positively associated with the use of semirecumbent positioning. Although this relationship was not statistically significant, the role nurses played in the use of semirecumbent positioning was clearly evident in our qualitative data. Specifically, our results illustrate the importance of having nurses directly engaged in promoting the use of semirecumbent positioning and maintaining adherence. Our results also suggest that nurses' misperceptions about their own adherence to this practice may be a barrier to its effective use. Likewise, other research shows that self‐reported adherence to semirecumbent positioning may be overestimated. According to surveys of ICU nurses, reported adherence to semirecumbent positioning (ie, head of bed raised 30°–45°) ranged from 76.4% to 86%.26,27 In contrast, a study in which patient position was observed in 3 ICUs (using 502 measurements of 169 patients) found that 120 (71%) of the 169 patients were supine and that the mean backrest elevation was 19° (16.8° for patients who received mechanical ventilation vs 23.1° for patients who did not).28 Therefore, monitoring may be an essential element to ensure the effective use of semirecumbent positioning, and nurses as well as other staff, including respiratory therapists, pharmacists, and ICPs, can perform this important function.

Unlike the use of semirecumbent positioning, nurses had minimal influence on the use of subglottic secretion drainage, which is to be expected, given that nurses rarely perform endotracheal intubation. However, a practice alert on VAP issued by the American Association of Critical‐Care Nurses in February 2004 identified the use of subglottic secretion drainage as one of 3 recommended practices, along with use of semirecumbent positioning and not routinely changing the ventilator circuit.29 Thus, nurses could conceivably be proponents of subglottic secretion drainage.

The extent to which evidence truly influences decisions about the use of infection prevention practices is not straightforward, as others have also found,30,31 and merits further investigation. Our qualitative results confirm that subglottic secretion drainage is a controversial practice for preventing VAP, and varying opinions and debates about the evidence supporting this technology are common. In comparison, we found no debate surrounding the use of semirecumbent positioning, even though the published CDC guidelines suggest that the level of evidence is similar for both practices.3 Moreover, a meta‐analysis of 5 randomized trials of subglottic secretion drainage generally supported this preventive practice,32 whereas there are only 2 published randomized trials of semirecumbent positioning,33,34 one of which concluded that it was ineffective at preventing the development of VAP.33

Even though we employed national sampling and achieved an excellent response rate, several important limitations of our study must be acknowledged. First, we relied on self‐reporting from the lead ICP at each hospital to determine what practices were being used to prevent VAP, and we have no mechanism to validate these reports. Although the lead ICP may have overstated or understated the use of the various practices, we have no evidence of systematic bias. Second, although our sampling strategy was designed to be nationally representative, it is possible that participating hospitals were different from nonparticipating hospitals, thereby decreasing the external validity of our survey results. Third, the qualitative portion of our study was conducted to understand why hospitals are doing what they are doing; the results are not intended to be representative of the more than 6,000 acute care hospitals in the United States. However, although our findings are not generalizable by statistical inference from the study sample to the population, they can be generalized to similar settings and can point to areas for further exploration.35

Despite these limitations, our multicenter, mixed‐methods study provides valuable information for policy makers, clinicians, and patient safety personnel interested in reducing VAP and other hospital‐acquired infections. First, collaboratives and the promotion of practice bundles can be powerful tools for increasing awareness and engaging hospitals in the use of specific infection prevention practices. However, the long‐term sustainability and potential unintended consequences of these types of initiatives are not yet fully understood. Second, although nurses may not be involved with the implementation of all prevention strategies, their involvement could play an important role in the use of many infection prevention practices. Finally, we need to understand better how evidence related to prevention practices is identified, interpreted, and used to ensure that research findings are reliably translated into clinical practice.

Acknowledgments

 

We thank Nasia Safdar, MD, MS, and Pat Rouen, MSN, RN, for their feedback and comments during manuscript preparation, and all those who participated as survey respondents or in interviews.

Financial support. This project was supported by the Department of Veterans Affairs Health Services Research and Development Service (grant SAF 04‐031) and the Ann Arbor VA Medical Center/University of Michigan Patient Safety Enhancement Program. S.S. is supported by an Advanced Career Development Award from the Health Services Research and Development Service of the Department of Veterans Affairs.

Potential conflicts of interest. All authors report no conflicts of interest relevant to this article.

Appendix

 

The main questions asked during the telephone interviews are shown below. The interviews were semistructured.

How did this hospital identify the need for the practice?

What kind of information did this hospital have on the practice?

Who were the important people who helped this hospital decide to use this practice?

What problems did this hospital run into getting this practice adopted?

Is this hospital experiencing any implementation problems?

What are the major barriers that prevented your hospital from implementing practices for reducing healthcare‐associated infections? What are the facilitators?

If I could fix one barrier here that makes it more difficult for your organization to implement key practices for preventing healthcare‐associated infections, what would you have me fix?

If someone wants to adopt a new infection control practice, what committees do they go through?

How does being part of a large healthcare system affect the adoption and implementation of infection control practices? What are the benefits? The barriers?

Who are the main people who need to be on board for change to occur?

Have collaboratives had a role in the adoption or implementation of infection control practices at this hospital?

How would you describe the prevailing management style in this hospital?

What is your perception of how senior management is involved in the adoption and implementation of infection control practices?

References

 
  • 1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical‐surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21:510–515.
  • 2. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator‐associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184–2193.
  • 3. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health‐care–associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53(RR‐3):1–36.
  • 4. Dodek P, Keenan S, Cook D, et al. Evidence‐based clinical practice guideline for the prevention of ventilator‐associated pneumonia. Ann Intern Med 2004; 141:305–313.
  • 5. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416.
  • 6. Collard HR, Saint S, Matthay MA. Prevention of ventilator‐associated pneumonia: an evidence‐based systematic review. Ann Intern Med 2003; 138:494–501.
  • 7. Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD. The 100,000 Lives Campaign: setting a goal and a deadline for improving health care quality. JAMA 2006; 295:324–327.
  • 8. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator‐associated pneumonia. Jt Comm J Qual Patient Saf 2005; 31:243–248.
  • 9. Youngquist P, Carroll M, Farber M, et al. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 2007; 33:219–225.
  • 10. Krein SL, Olmsted RN, Hofer TP, et al. Translating infection prevention evidence into practice using quantitative and qualitative research. Am J Infect Control 2006; 34:507–512.
  • 11. Krein S, Hofer T, Kowalski C, et al. Use of central venous catheter‐related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc 2007; 82:672–678.
  • 12. Saint S, Kowalski CP, Kaufman SR, et al. Preventing hospital‐acquired urinary tract infection in the United States: a national study. Clin Infect Dis 2008; 46:243–250.
  • 13. Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed‐method studies. Res Nurs Health 2000; 23:246–255.
  • 14. Ivankova NV, Creswell JW, Stick SL. Using mixed‐methods sequential explanatory design: from theory to practice. Field Methods 2006; 18:3–20.
  • 15. National Center for Health Workforce Analysis Bureau of Health Professions, Health Resources and Services Administration, Department of Health and Human Services. Area Resource File (ARF). Fairfax, VA: Quality Resource Systems (QRS), Inc.; 2003.
  • 16. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse‐staffing levels and quality of care in hospitals. N Engl J Med 2002; 346:1715–1722.
  • 17. Putnam W, Twohig PL, Burge FI, Jackson LA, Cox JL. A qualitative study of evidence in primary care: what the practitioners are saying. CMAJ 2002; 166:1525–1530.
  • 18. Kane RL, Shamliyan T, Mueller C, Duval S, Wilt TJ. Nurse staffing and quality of patient care. Evid Rep Technol Assess (Full Rep) 2007; (151):1–115.
  • 19. Mason J. Qualitative researching. Thousand Oaks, CA: Sage Publications; 2002.
  • 20. Sandelowski M, Barroso J. Writing the proposal for a qualitative research methodology project. Qual Health Res 2003; 13:781–820.
  • 21. Forman J, Damschroder LJ. Qualitative content analysis. In: Jacoby L, Siminoff L, eds. Empirical Research for Bioethics: A Primer. Oxford, UK: Elsevier Publishing; 2008:39–62.
  • 22. Ovretveit J, Bate P, Cleary P, et al. Quality collaboratives: lessons from research. Qual Saf Health Care 2002; 11:345–351.
  • 23. Wilson T, Berwick DM, Cleary PD. What do collaborative improvement projects do? Experience from seven countries. Jt Comm J Qual Saf 2003; 29:85–93.
  • 24. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter‐related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725–2732.
  • 25. Wachter RM, Pronovost PJ. The 100,000 Lives Campaign: a scientific and policy review. Jt Comm J Qual Patient Saf 2006; 32:621–627.
  • 26. Ricart M, Lorente C, Diaz E, Kollef MH, Rello J. Nursing adherence with evidence‐based guidelines for preventing ventilator‐associated pneumonia. Crit Care Med 2003; 31:2693–2696.
  • 27. Cason CL, Tyner T, Saunders S, Broome L. Nurses’ implementation of guidelines for ventilator‐associated pneumonia from the Centers for Disease Control and Prevention. Am J Crit Care 2007;16:28–36.
  • 28. Grap MJ, Munro CL, Bryant S, Ashtiani B. Predictors of backrest elevation in critical care. Intensive Crit Care Nurs 2003; 19:68–74.
  • 29. American Association of Critical‐Care Nurses Practice Alert. Ventilator Associated Pneumonia. Available at: http://www.aacn.org/AACN/practiceAlert.nsf/vwdoc/pa2. Accessed January 3, 2008.
  • 30. Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence‐based guidelines for preventing ventilator‐associated pneumonia? A survey based on the opinions of an international panel of intensivists. Chest 2002; 122:656–661.
  • 31. Kaynar AM, Mathew JJ, Hudlin MM, et al. Attitudes of respiratory therapists and nurses about measures to prevent ventilator‐associated pneumonia: a multicenter, cross‐sectional survey study. Respir Care 2007; 52:1687–1694.
  • 32. Dezfulian C, Shojania K, Collard HR, Kim HM, Matthay MA, Saint S. Subglottic secretion drainage for preventing ventilator‐associated pneumonia: a meta‐analysis. Am J Med 2005; 118:11–18.
  • 33. van Nieuwenhoven CA, Vandenbroucke‐Grauls C, van Tiel FH, et al. Feasibility and effects of the semirecumbent position to prevent ventilator‐associated pneumonia: a randomized study. Crit Care Med 2006; 34:396–402.
  • 34. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer N. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354:1851–1858.
  • 35. Forman J, Creswell JW, Damschroder L, Kowalski CP, Krein, SL. Qualitative research methods: key features and insights gained by their use in infection prevention research. Am J Infect Control 2008. In press.
  • The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.

    Presented in part: 18th Annual Meeting of the Society for Healthcare Epidemiology of America; Orlando, Florida; April 5–8, 2008 (Abstract 378).

© 2008 by The Society for Healthcare Epidemiology of America. All rights reserved.